DE2721857A1 - N,n-dimethyl-3-(4-bromphenyl)-3- (3-pyridyl)-allylamindihydrochloridmonohydrat, verfahren zu dessen herstellung und es enthaltende arzneimittel - Google Patents

N,n-dimethyl-3-(4-bromphenyl)-3- (3-pyridyl)-allylamindihydrochloridmonohydrat, verfahren zu dessen herstellung und es enthaltende arzneimittel

Info

Publication number
DE2721857A1
DE2721857A1 DE19772721857 DE2721857A DE2721857A1 DE 2721857 A1 DE2721857 A1 DE 2721857A1 DE 19772721857 DE19772721857 DE 19772721857 DE 2721857 A DE2721857 A DE 2721857A DE 2721857 A1 DE2721857 A1 DE 2721857A1
Authority
DE
Germany
Prior art keywords
pyridyl
dimethyl
bromophenyl
allylamine
dihydrochloride monohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772721857
Other languages
German (de)
English (en)
Inventor
Carl Bengt Johan Ulff
Thore Oskar Vaerner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra USA Inc
Original Assignee
Astra Pharmaceutical Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharmaceutical Products Inc filed Critical Astra Pharmaceutical Products Inc
Publication of DE2721857A1 publication Critical patent/DE2721857A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19772721857 1976-05-21 1977-05-14 N,n-dimethyl-3-(4-bromphenyl)-3- (3-pyridyl)-allylamindihydrochloridmonohydrat, verfahren zu dessen herstellung und es enthaltende arzneimittel Withdrawn DE2721857A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7605780A SE409706B (sv) 1976-05-21 1976-05-21 Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat

Publications (1)

Publication Number Publication Date
DE2721857A1 true DE2721857A1 (de) 1977-12-01

Family

ID=20327944

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772721857 Withdrawn DE2721857A1 (de) 1976-05-21 1977-05-14 N,n-dimethyl-3-(4-bromphenyl)-3- (3-pyridyl)-allylamindihydrochloridmonohydrat, verfahren zu dessen herstellung und es enthaltende arzneimittel

Country Status (19)

Country Link
JP (1) JPS539311A (cg-RX-API-DMAC7.html)
AU (1) AU512004B2 (cg-RX-API-DMAC7.html)
BE (1) BE842368A (cg-RX-API-DMAC7.html)
CA (1) CA1093560A (cg-RX-API-DMAC7.html)
CY (1) CY1171A (cg-RX-API-DMAC7.html)
DE (1) DE2721857A1 (cg-RX-API-DMAC7.html)
DK (1) DK147048C (cg-RX-API-DMAC7.html)
FI (1) FI67696C (cg-RX-API-DMAC7.html)
FR (1) FR2351964A1 (cg-RX-API-DMAC7.html)
GB (1) GB1561286A (cg-RX-API-DMAC7.html)
HK (1) HK55782A (cg-RX-API-DMAC7.html)
IE (1) IE45385B1 (cg-RX-API-DMAC7.html)
LU (1) LU77244A1 (cg-RX-API-DMAC7.html)
MY (1) MY8400046A (cg-RX-API-DMAC7.html)
NL (1) NL7705529A (cg-RX-API-DMAC7.html)
NO (1) NO150000C (cg-RX-API-DMAC7.html)
NZ (1) NZ184146A (cg-RX-API-DMAC7.html)
SE (1) SE409706B (cg-RX-API-DMAC7.html)
SG (1) SG60682G (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7909514L (sv) 1979-11-16 1981-05-17 Astra Laekemedel Ab Nya halofenyl-pyridyl-allylaminderivat
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
EP0919550A1 (en) 1997-11-26 1999-06-02 Ucb, S.A. Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2220333C3 (de) * 1971-04-28 1979-11-22 Ab Haessle, Goeteborg (Schweden) 3-(4-Bromphenyl)-3-(pyridyl)dimethylallylamine, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2220333C3 (de) * 1971-04-28 1979-11-22 Ab Haessle, Goeteborg (Schweden) 3-(4-Bromphenyl)-3-(pyridyl)dimethylallylamine, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel

Also Published As

Publication number Publication date
NL7705529A (nl) 1977-11-23
FI771591A7 (cg-RX-API-DMAC7.html) 1977-11-22
NO771774L (no) 1977-11-22
LU77244A1 (cg-RX-API-DMAC7.html) 1977-08-22
FI67696B (fi) 1985-01-31
GB1561286A (en) 1980-02-20
AU2513577A (en) 1978-11-16
SG60682G (en) 1983-09-02
FI67696C (fi) 1985-05-10
MY8400046A (en) 1984-12-31
DK147048C (da) 1984-09-03
IE45385B1 (en) 1982-08-11
NO150000B (no) 1984-04-24
SE7605780L (sv) 1977-11-22
BE842368A (fr) 1976-09-16
HK55782A (en) 1983-01-07
SE409706B (sv) 1979-09-03
CA1093560A (en) 1981-01-13
DK221177A (da) 1977-11-22
IE45385L (en) 1977-11-21
NO150000C (no) 1984-08-01
FR2351964A1 (fr) 1977-12-16
NZ184146A (en) 1979-07-11
JPS539311A (en) 1978-01-27
CY1171A (en) 1983-06-10
FR2351964B1 (cg-RX-API-DMAC7.html) 1981-03-20
AU512004B2 (en) 1980-09-18
DK147048B (da) 1984-03-26

Similar Documents

Publication Publication Date Title
DE29724281U1 (de) 4-Phenylpiperidin-Verbindungen
DE60035109T2 (de) Verfahren zur herstellung von thiamethoxam
CH631164A5 (de) Verfahren zur herstellung von neuem 1-cyclopropylmethyl-4-(3-jod-5h-dibenzo(a,d)cyclohepten-5-yliden)piperidin.
DE1957722C3 (de) Substituierte 2- [N-Aminoalkyl-N-(2,6dichlorphenyl)-amino] -imidazoline-^), deren Säureadditionssalze, Verfahren zu ihrer Herstellung und deren Verwendung
EP0075752B1 (de) Substituierte 2-Phenyl-2-(pyridyloxy)-ethylamine und isostere Verbindungen, Verfahren zu ihrer Herstellung und Verwendung
DE68905171T2 (de) Benzol-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die diese enthalten.
DE2721857A1 (de) N,n-dimethyl-3-(4-bromphenyl)-3- (3-pyridyl)-allylamindihydrochloridmonohydrat, verfahren zu dessen herstellung und es enthaltende arzneimittel
DE2757532A1 (de) N,n'-disubstituiertes cyclisches diamin und verfahren zu dessen herstellung
DE2130673A1 (de) Diphenylmethylimidazole,Verfahren zu ihrer Herstellung und ihre Verwendung als Fungizide
CH615665A5 (en) Process for the preparation of the Z-isomer of 3-(4-bromophenyl)-N-methyl-3-(3-pyridyl)allylamine
DE2213271C3 (de) Neue oxazolidine
EP0092185B1 (de) Mefloquin-hydrochlorid und Verfahren zu seiner Reindarstellung
DE2756852A1 (de) 1-amino-niedrig-alkyl-3,4-diphenyl- 1h-pyrazole
EP1077950B1 (de) Neue diphenyl-substituierte 6-ring heterocyclen, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
CH615153A5 (cg-RX-API-DMAC7.html)
DE1131679B (de) Verfahren zur Herstellung von Phenthiazinverbindungen
EP0182271B1 (de) Neue Nb-quartäre Dibromderivate von Ajmalin, Isoajmalin, Sandwicin und Isosandwicin sowie diese Derivate enthaltende pharmazeutische Zubereitungen und Zwischenprodukte und Verfahren zu ihrer Herstellung
DE1901175A1 (de) Verfahren zur Herstellung von neuen Piperidinderivaten
AT219036B (de) Verfahren zur Herstellung von neuen 3-substituierten 1-Benzylindanen und deren Salzen
AT216003B (de) Verfahren zur Herstellung von basisch substituierten Thiaxanthenen sowie von deren Säureadditionssalzen
DE2251154B2 (de) 2-Aminoalkylthio-4-(p-thiophenyl)-3H-l,5-benzodiazepinderivate, solche enthaltende Arzneimittel und Desinfektionsmittel und Verfahren zu ihrer Herstellung
KR810001704B1 (ko) N, n-디메틸-3-(4-브로모페닐)-3-(3-피리딜)-알릴아민 디하이드로클로라이드 모노하이드레이트의 제조 방법
AT211001B (de) Verfahren zur Herstellung von neuen Scopin-äthern
AT247341B (de) Verfahren zur Herstellung von neuen, basisch substituierten Phenothiazinen
DE1923250C3 (de) 7-Chlor-5-(2-fluorphenyl)-1-(2-hydroxyäthyl)-1,3-dihydro-2-H-1,4-benzodiazepin-2-on

Legal Events

Date Code Title Description
OGA New person/name/address of the applicant
8110 Request for examination paragraph 44
8139 Disposal/non-payment of the annual fee